Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
LP-001 by LintonPharm for Breast Cancer: Likelihood of Approval
LP-001 is under clinical development by LintonPharm and currently in Phase I for Breast Cancer. According to GlobalData, Phase I...
LP-001 by LintonPharm for Lung Cancer: Likelihood of Approval
LP-001 is under clinical development by LintonPharm and currently in Phase I for Lung Cancer. According to GlobalData, Phase I...
LP-001 by LintonPharm for Colorectal Cancer: Likelihood of Approval
LP-001 is under clinical development by LintonPharm and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase I...
LP-001 by LintonPharm for Gastric Cancer: Likelihood of Approval
LP-001 is under clinical development by LintonPharm and currently in Phase I for Gastric Cancer. According to GlobalData, Phase I...
LP-001 by LintonPharm for Epithelial Tumor: Likelihood of Approval
LP-001 is under clinical development by LintonPharm and currently in Phase I for Epithelial Tumor. According to GlobalData, Phase I...
LP-001 by Tianchen Biopharmaceutical (Suzhou) for Anemia: Likelihood of Approval
LP-001 is under clinical development by Tianchen Biopharmaceutical (Suzhou) and currently in Phase I for Anemia. According to GlobalData, Phase...